@article{322faf95329a4634b4f1d9e2db3f9739,
title = "Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry",
abstract = "To investigate frequencies and reasons for switching, treatment responses and drug survival in patients with ankylosing spondylitis (AS) switching tumour-necrosis-factor-α inhibitor (TNFi) treatment in routine clinical care.",
keywords = "Adult, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Denmark, Drug Substitution, Female, Humans, Immunoglobulin G, Male, Medication Adherence, Middle Aged, Pain Measurement, Receptors, Tumor Necrosis Factor, Registries, Spondylitis, Ankylosing, Treatment Outcome, Tumor Necrosis Factor-alpha",
author = "Bente Glintborg and Mikkel {\O}stergaard and Krogh, {Niels Steen} and Ulrik Tarp and Natalia Manilo and Loft, {Anne Gitte Rasmussen} and Annette Hansen and Annette Schlemmer and Victoria Fana and Lindegaard, {Hanne M} and Henrik Nordin and Claus Rasmussen and Leif Ejstrup and Jensen, {Dorte Vendelbo} and Petersen, {Peter Mosborg} and Hetland, {Merete Lund}",
year = "2013",
month = jul,
doi = "10.1136/annrheumdis-2012-201933",
language = "English",
volume = "72",
pages = "1149--55",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "7",
}